Lv11
94 积分 2024-02-29 加入
Sotorasib induces intestinal epithelial injury through suppression of the cAMP/PKA/CREB signaling axis
7小时前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
9天前
已完结
Regional specialization within the intestinal immune system
13天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
26天前
已完结
ALK in cancer: from function to therapeutic targeting
28天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
1个月前
已完结
ALK in cancer: from function to therapeutic targeting
1个月前
已完结
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance
1个月前
已完结
Novel drug targets in 2025
1个月前
已完结
Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses
1个月前
已完结
皖公网安备34019202002308
